Yahoo
NYSE - Delayed Quote USD

AbbVie Inc. (ABBV)

256.46 -3.75 (-1.44%)
At close: September 4 at 4:03:55 PM EDT
260.72 +4.26 (+1.66%)
After hours: September 4 at 7:59:03 PM EDT
Trade AbbVie on Coinbase

News headlines

Updated 57m ago
Powered by Yahoo Scout

AbbVie is making strides in oncology with its myeloma drug etentamig, showing a 74% response ratein trials, while navigating the challenges posed by declining Humira sales. Analysts are optimistic about AbbVie’s revenue growth, projecting $67.2 billionin sales for 2026.

Mobilize your Website
View Site in Mobile | Classic
Share by: